TITLE

Difficult asthma in children

AUTHOR(S)
McKenzie, S. A.; Bush, A.
PUB. DATE
October 2002
SOURCE
Thorax;Oct2002, Vol. 57 Issue 10, p915
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
One study of computerised prescribing databases showed that fewer than one in six parents were collecting sufficient prescriptions to cover regular prophylactic asthma medication for their children. Asthmatic children on high dose corticosteroids need to be fully assessed to ensure that such dosages are really necessary. Probably the most common reason for the escalation of children's prescribed inhaled corticosteroid dosage is that parents do not supervise treatment and then report poor control.
ACCESSION #
16181818

 

Related Articles

  • Treatment Comparison of Budesonide/ Formoterol with Salmeterol/Fluticasone Propionate in Adults Aged ≥16 Years with Asthma: Post Hoc Analysis of a Randomized, Double-Blind Study. Kuna, Piotr // Clinical Drug Investigation;2010, Vol. 30 Issue 9, p565 

    Background: Three fixed maintenance-dose inhaled corticosteroid/long-acting β2-agonist (ICS/LABA) combinations for the treatment of asthma are currently available: salmeterol/fluticasone propionate (Seretide™/Advair™/ Adoair™) budesonide/formoterol (Symbicort®) and...

  • Magnesium and Outcomes in Children with Acute Asthma. Sadovsky, Richard // American Family Physician;6/15/2001, Vol. 63 Issue 12, p2441 

    Presents information on a study by R.J. Scarfone and others that studied the early administration of magnesium to moderately to severely ill children with asthma in a randomized, double-blind, placebo-controlled clinical trial. Description of the study and its results; Conclusion that among a...

  • Montelukast vs. Inhaled Low-Dose Budesonide as Monotherapy in the Treatment of Mild Persistent Asthma: A Randomized Double Blind Controlled Trial. Vikram Kumar; P. Ramesh; Rakesh Lodha; R. M. Pandey; S. K. Kabra // Journal of Tropical Pediatrics;Oct2007, Vol. 53 Issue 5, p325 

    Background: Guidelines recommend daily controller therapy for mild persistent asthma. Montelukast has demonstrated consistent benefit in controlling symptoms of asthma and may be an alternative, orally administered, nonsteroidal agent for treating mild asthma. Aim: To determine whether...

  • ASSESSMENT OF THE ADVERSE EFFECTS OF LOW DOSES INHALED CORTICOSTEROIDS IN ASTHMATIC CHILDREN. MOHOR, C. // Acta Medica Transilvanica;dec2012, Vol. 17 Issue 4, p269 

    The way in which inhaled corticosteroids influence the growth and the development of the children with asthma is relatively little studied, the results being often contradictory. The study was conducted on two hundred subjects with one hundred children with asthma treated with inhaled...

  • Pediatrik zor astım ve tedavisi. Yüksel, Hasan // Turkish Pediatrics Archive / Turk Pediatri Arsivi;jun2010 supplement, Vol. 45, p1 

    Difficult asthma which constitutes less than 5% of all childhood asthma cases is defined as presence of daily symptoms, frequent oral corticosteroid requirement and frequent exacerbations for longer than six months, despite the use of inhaled steroid equivalent to 500 mcg fluticasone propionate,...

  • Editorial [Guest Editor: Strategies for the Improvement of Asthma Therapy (Executive Editor: Andreas Pahl)]. Pahl, Andreas // Current Pharmaceutical Design;Sep2006, Vol. 12 Issue 25, p3173 

    Asthma bronchiale, affecting 155 millions people worldwide, has emerged as a major public health problem worldwide over the past 20 years. Although data indicate that current asthma therapies led to limited decreases in death rates, it continues to be a significant health care problem. As we...

  • Asthma: Principles of Treatment. Story, Rachel E.; Tripathi, Anju // Allergy & Asthma Proceedings;Jul/Aug2004, Vol. 25, pS26 

    The article presents information on the principles of treatment of Asthma. Proper treatment of asthma requires an accurate diagnosis of the type of asthma (allergic versus non allergic) as well as its severity. Once a diagnosis is established, coexisting conditions that affect asthma severity...

  • Omalizumab for Asthma: Indications, Off-Label Uses and Future Directions. Ben-Shoshan, Moshe // Recent Patents on Inflammation & Allergy Drug Discovery;Nov2010, Vol. 4 Issue 3, p183 

    Omalizumab is a recombinant humanized monoclonal antibody. Use of omalizumab is reported to benefit significantly a subset of asthmatics patients with inadequately controlled moderate-to-severe persistent allergic asthma that is not controlled with high-dose inhaled corticosteroids. However,...

  • Inhaled corticosteroids and decline of lung function in community residents with asthma. Lange, P.; Scharling, H.; Ulrik, C. S.; Vestbo, J. // Thorax;Feb2006, Vol. 61 Issue 2, p100 

    Background: Inhaled corticosteroids (ICS) constitute the cornerstone of treatment for asthma. Many studies have reported beneficial short term effects of these drugs, but there are few data on the long term effects of ICS on the decline in forced expiratory volume in 1 second (FEV1). This study...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics